Tetrahydropalmatine attenuates liver fibrosis by suppressing endoplasmic reticulum stress in hepatic stellate cells

Chin Med J (Engl). 2021 Dec 30;135(5):628-630. doi: 10.1097/CM9.0000000000001883.

Authors

Yuanyuan Xuan¹, Shiyun Chen², Xin Ding³, Lexun Wang⁴, Shengwen Li³, Guizhi Yang¹, Tian Lan^{1

4}

Affiliations

¹ Institute of Chinese Medicine, Guangdong Pharmaceutical University, Guangzhou, Guangdong 510006, China.
² School of Pharmacy, Guangdong Pharmaceutical University, Guangzhou, Guangdong 510006, China.
³ Clinical Medicine, Guangdong Pharmaceutical University, Guangzhou, Guangdong 510006, China.
⁴ Guangdong Metabolic Diseases Research Center of Integrated Chinese and Western Medicine, Guangzhou, Guangdong 510006, China.

No abstract available

MeSH terms

Berberine Alkaloids* / pharmacology
Berberine Alkaloids* / therapeutic use
Endoplasmic Reticulum Stress
Hepatic Stellate Cells* / pathology
Humans
Liver Cirrhosis / drug therapy
Liver Cirrhosis / pathology

Substances

Berberine Alkaloids
tetrahydropalmatine